| Angela S Liefer, MED, LCPC | |
|
2615 Edwards St, Alton, IL 62002-3915 | |
| (618) 462-2331 | |
| (618) 462-2504 |
| Full Name | Angela S Liefer |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 2615 Edwards St, Alton, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285911065 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 180008036 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Angela S Liefer, MED, LCPC 2615 Edwards St, Alton, IL 62002-3915 Ph: (618) 462-2331 | Angela S Liefer, MED, LCPC 2615 Edwards St, Alton, IL 62002-3915 Ph: (618) 462-2331 |
News Archive
The District of Columbia Patients' Cooperative (DCPC), a non-profit, medical cannabis organization registered in the District of Columbia, has submitted comments to the Office of the DC Attorney General addressing numerous issues on proposed regulations announced 45 days ago.
Allos Therapeutics, Inc. today announced that it is offering to sell, subject to market and other conditions, 11,000,000 primary shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.
Cell Therapeutics, Inc. and Chroma Therapeutics Ltd. announced that interim results from the phase II OPAL study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (AML) were presented by Jorge Cortes, M.D. and discussed at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO) by Farhad Ravandi, M.D., who presided over the ASCO discussion session, both of the University of Texas M.D. Anderson Cancer Center.
Female COVID-19 patients face less severe disease complications and a lower risk of dying than male patients thanks to hormones and chromosomes that contribute to a stronger immune response, according to new research from a University of Alberta-led team.
For long-term treatment of newly diagnosed Parkinson's disease (PD), the old drug levodopa provides better mobility and a higher quality of life than the two main alternatives, dopamine agonists (DA) and monoamine oxidase type B inhibitors (MAOBI), according to the largest-ever trial of PD treatment (PD MED), published in The Lancet.
› Verified 8 days ago
Elissha Lenhardt, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-2504 | |
Jennifer Tapen, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-2504 | |
Emily Pembrook, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-2504 | |
Joshua Lupardus, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-7160 | |
Lauren Lumpkins, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-2504 | |
Erin Loebner, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-2504 | |
Ms. Linda K Moffatt, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 611 W Delmar Ave, Alton, IL 62002 Phone: 618-791-8006 Fax: 618-243-6558 |